Related Experiment Video

Updated: Aug 23, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Recent developments in target identification against hepatitis C virus

Volker Brass1, Hubert E Blum, Darius Moradpour

  • 1Department of Medicine II, University of Freiburg, D-79106 Freiburg, Germany. Darius.Moradpour@uni-freiburg.de

Expert Opinion on Therapeutic Targets
|July 23, 2004
PubMed

Insights

New hepatitis C virus (HCV) therapies targeting viral serine protease show promise. These advancements in antiviral strategies offer potential new treatments for chronic hepatitis C, a major cause of liver disease.

Area of Science:

  • Hepatology
  • Virology
  • Drug Discovery

Background:

  • Chronic hepatitis C is a significant global health issue, leading to liver cirrhosis and hepatocellular carcinoma.
  • Understanding hepatitis C virus (HCV) molecular virology has identified new targets for antiviral therapies.

Purpose of the Study:

  • To evaluate novel therapeutic strategies for chronic hepatitis C.
  • To report on the efficacy of a specific HCV serine protease inhibitor.

Main Methods:

  • Development of in vitro and in vivo model systems for evaluating therapeutic strategies.
  • Conducting proof-of-concept clinical studies for novel antiviral agents.

Main Results:

  • Positive results reported from proof-of-concept clinical studies.
  • A specific hepatitis C virus serine protease inhibitor demonstrated efficacy.

Conclusions:

  • Novel antiviral strategies, including serine protease inhibitors, show potential for treating chronic hepatitis C.
  • These new approaches may enhance current treatment options for hepatitis C virus infection.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...